Everolimus-induced Symmetrical Drug-related Intertriginous and Flexural Exanthema
Acta Derm Venereol
.
2023 Dec 19:103:adv12197.
doi: 10.2340/actadv.v103.12197.
Authors
Emily Y Kim
1
,
Katherine C Awh
1
,
Cecilia A Larocca
2
Affiliations
1
Center for Cutaneous Oncology, Dana-Farber Brigham Cancer Center, Boston, MA, USA.
2
Department of Dermatology, Brigham and Women's Hospital, 41 Louis Pasteur Avenue, Boston MA 02115, USA.
[email protected]
.
PMID:
38112207
PMCID:
PMC10753590
DOI:
10.2340/actadv.v103.12197
No abstract available
MeSH terms
Drug Eruptions* / diagnosis
Drug Eruptions* / etiology
Everolimus / adverse effects
Exanthema* / chemically induced
Exanthema* / diagnosis
Humans
Substances
Everolimus